Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV

References

• UNAIDS, [Internet]. Ethiopia; 2018 Available from: https://www.unaids.org/en/regionscountries/countries/ethiopia. Accessed 815, 2020.
   Google Scholar
• EDHS. HIV Prevalence report in Ethiopia data from the Ethiopia demographic and health survey; 2016 Available from: https://dhsprogram.com/pubs/pdf/FR328/FR328.HIV.pdf. Accessed 815, 2020.
   Google Scholar
• Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry. 2000;69(3):376–380. doi:10.1136/jnnp.69.3.37610945813
   PubMedGoogle Scholar
• Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8(2):136–142. doi:10.1080/1355028029004961511935465
   PubMed Web of Science ®Google Scholar
• McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology. 1993;43(11):2245–2252. doi:10.1212/wnl.43.11.22458232937
   PubMed Web of Science ®Google Scholar
• Zhang YL, Ouyang YB, Liu LG, Chen DX. Blood-brain barrier and neuro-AIDS. Eur Rev Med Pharmacol Sci. 2015;19(24):4927–4939.26744885
   PubMed Web of Science ®Google Scholar
• Kopstein M, Mohlman DJ. HIV-1 encephalopathy and aids dementia complex In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 6 30.
   Google Scholar
• Petito CK, Navia BA, Cho E-S, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985;312(14):874–879. doi:10.1056/NEJM1985040431214023974673
   PubMed Web of Science ®Google Scholar
• Shapshaka P, Kangueane P, Fujimurae RK, et al. Editorial NeuroAIDS review. spAIDS. 2011;25(2):123–141.
   Google Scholar
• Spudich S, Gisslen M, Hagberg L, et al. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011;204(5):753–760. doi:10.1093/infdis/jir38721844301
   PubMed Web of Science ®Google Scholar
• Klunder AD, Chiang MC, Dutton RA, et al. Mapping cerebellar degeneration in HIV/AIDS. Neuroreport. 2008;19(17):1655–1659. doi:10.1097/WNR.0b013e328311d37418806691
   PubMed Web of Science ®Google Scholar
• Cole MA, Castellon SA, Perkins AC, et al. Relationship between psychiatric status and frontal–subcortical systems in HIV-infected individuals. J Int Neuropsychol Soc. 2007;13(3):549–554.17445305
   PubMed Web of Science ®Google Scholar
• Saylor D, Dickens AM, Sacktor N, et al. HIV-associated neurocognitive disorder - Pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12(4):234–248.26965674
   PubMed Web of Science ®Google Scholar
• Cheng S, Klein H, Bartsch DU, Kozak I, Marcotte TD, Freeman WR. Relationship between retinal nerve fiber layer thickness and driving ability in patients with human immunodeficiency virus infection. Graefes Arch Clin Exp Ophthalmol. 2011;249(11):1643–1647. doi:10.1007/s00417-011-1735-421732109
   PubMedGoogle Scholar
• Nabha L, Duong L, Timpone J. HIV-associated neurocognitive disorders: perspective on management strategies. Drugs. 2013;73(9):893–905. doi:10.1007/s40265-013-0059-623733447
   PubMedGoogle Scholar
• Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–1799. doi:10.1212/01.WNL.0000287431.88658.8b17914061
   PubMed Web of Science ®Google Scholar
• Heaton RK, Clifford DB, Franklin DR, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: charter Study. Neurology. 2010;75(23):2087–2096.21135382
   PubMed Web of Science ®Google Scholar
• McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. 2004;157(12):3–10. doi:10.1016/j.jneuroim.2004.08.04215579274
   PubMedGoogle Scholar
• Manzar MD, Salahuddin M, Sony P, et al. Sleep disturbances and memory impairment among pregnant women consuming khat: an under‑recognized problem. Ann Thorac Med. 2017;12(4):247–251. doi:10.4103/atm.ATM_24_1729118856
   PubMedGoogle Scholar
• Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243–1250. doi:10.1097/QAD.0b013e3283354a7b19996937
   PubMed Web of Science ®Google Scholar
• Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: A new rapid screening test for HIV dementia. Aids. 2005;19(13):1367–1374.16103767
   PubMed Web of Science ®Google Scholar
• Singh D, Sunpath H, John S, Eastham LGR. The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts- a preliminary report. Afr J Psychiatry. 2008;11(4):282–286.
   Google Scholar
• World Health Organization. Interim WHO clinical staging of HVI/AIDS and HIV/AIDS case definitions for surveillance: african Region; ‎2005 Available from: https://apps.who.int/iris/handle/10665/69058. Accessed 815, 2020.
   Google Scholar
• Kumar S, Himanshu D, Tandon R, Atam V, Sawlani KK, Verma SK. Prevalence of hiv associated neurocognitive disorder using modified mini mental state examination and its correlation with CD4 counts and anti-retroviral therapy. J Assoc Physicians India. 2019;67(4):47–51.
   PubMedGoogle Scholar
• Bhaskaran K, Mussini C, Antinori A, et al. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. 2008;63(2):213–221. doi:10.1002/ana.2122517894380
   PubMed Web of Science ®Google Scholar
• Yakasai AM, Gudaji MI, Muhammad H, et al. Prevalence and correlates of HIV-associated neurocognitive disorders (HAND) in Northwestern Nigeria. Neurol Res Int. 2015;2015.
   Google Scholar
• Alford K, Banerjee S, Nixon E, et al. Assessment and management of HIV-associated cognitive impairment: experience from a multidisciplinary memory service for people living with HIV. Brain Sci. 2019;9(2):1–13.
   Web of Science ®Google Scholar
• Animut MD, Sorrie MB, Birhanu YW, Teshale MY. High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study. PLoS One. 2019;14(3):1–15. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L2001727802%0Ahttp://dx.doi.10.1371/journal.pone.0204636
   Web of Science ®Google Scholar
• Yusuf AJ, Hassan A, Mamman AI, Muktar HM, Suleiman AM, Baiyewu O. Prevalence of HIV-Associated Neurocognitive Disorder (HAND) among Patients Attending a Tertiary Health Facility in Northern Nigeria. J Int Assoc Provid AIDS Care. 2017;16(1):48–55. doi:10.1177/232595741455383925331222
   PubMedGoogle Scholar
• Thai TT, Jones MK, Harris LM, Heard RC. Prevalence and correlates of probable HIV-associated dementia in HIV outpatients in Ho Chi Minh City, Vietnam. J Int Assoc Provid AIDS Care. 2017;16(4):366–375. doi:10.1177/232595741770119528367733
   PubMedGoogle Scholar
• Kinai E, Komatsu K, Sakamoto M, et al. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study. J Neurovirol. 2017;23(6):864–874. doi:10.1007/s13365-017-0580-628971376
   PubMed Web of Science ®Google Scholar
• Gandhi NS, Moxley RT, Creighton J, et al. Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Ther. 2010;4(3):371–379. doi:10.2217/hiv.10.2320824119
   PubMedGoogle Scholar
• Skinner S, Adewale AJ, Deblock L, Gill MJ, Power C. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Med. 2009;10(4):246–252.19187172
   PubMed Web of Science ®Google Scholar
• Belete T, Medfu G, Yemiyamrew E. Prevalence of HIV associated neurocognitive deficit among hiv positive people in ethiopia: a cross sectional study at ayder referral hospital. Ethiop J Health Sci. 2017;27(1):67–76. doi:10.4314/ejhs.v27i1.928458492
   PubMedGoogle Scholar
• Habib AG, Yakasai AM, Owolabi LF, et al. Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis. 2013;17(10):e820e831. doi:10.1016/j.ijid.2013.06.01123953699
   PubMedGoogle Scholar
• Oshinaike OO, Akinbami AA, Ojo OO, Ojini IF, Okubadejo UN, Danesi AM. Comparison of the minimental state examination scale and the international hiv dementia scale in assessing cognitive function in nigerian HIV patients on antiretroviral therapy. AIDS Res Treat. 2012;2012.
   Google Scholar
• Ogunrin. The burden of HIV-associated dementia in acquired immunodeficiency syndrome: a case-control study. J Neurol Epidemiol. 2013.
   Google Scholar
• Atashili J, Gaynes BN, Pence BW, et al. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: A cross-sectional study. BMC Neurol. 2013:13(1); 1. doi:10.1186/1471-2377-13-8623282097
   PubMedGoogle Scholar
• Achappa B, Priyadarshni S, Madi D, et al. Neurocognitive dysfunction among HIV positive patients using International HIV dementia scale. Asian J Med Sci. 2014;5(4):61–64. doi:10.3126/ajms.v5i4.8724
   Google Scholar
• Nakku J, Kinyanda E, Hoskins S. Prevalence and factors associated with probable HIV dementia in an African population: A cross-sectional study of an HIV/AIDS clinic population. BMC Psychiatry. 2013;13:126. doi:10.1186/1471-244X-13-12623641703
   PubMedGoogle Scholar
• Miller G. Drug targeting. Breaking down barriers. Science. 2002;297(5584):1116–1118. doi:10.1126/science.297.5584.111612183610
   PubMed Web of Science ®Google Scholar
• Childs EA, Lyles RH, Selnes EA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52(3):607. doi:10.1212/WNL.52.3.60710025796
   PubMed Web of Science ®Google Scholar
• Wong MH, Robertson K, Nakasujja N, et al. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. 2007;68(5):350–355. doi:10.1212/01.wnl.0000252811.48891.6d17261681
   PubMed Web of Science ®Google Scholar
• Becker JT, Lopez OL, Dew MAAH. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004;18(1):S11–8. doi:10.1097/00002030-200401001-0000315075493
   PubMedGoogle Scholar
• Nakasujja N, Skolasky R L, Musisi S, et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry. 2010;10.20109169
   PubMedGoogle Scholar
• Tozzi V, Balestra P, Lorenzini P, et al. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol. 2005;11(3):265–273. doi:10.1080/1355028059095279016036806
   PubMed Web of Science ®Google Scholar
• Manzar MD, Salahuddin M, Maru TT, et al. Sleep correlates of substance use in community-dwelling Ethiopian adults. Sleep Breath. 2017;21(4):1005–1011. doi:10.1007/s11325-017-1567-528884262
   PubMed Web of Science ®Google Scholar
• Juárez-Portilla C, Molina-Jiménez T, Morin J, Roldán-Roldán G, Zepeda R. Influence of drugs on cognitive function. Intech. 2016.
   Google Scholar
• Gould TJ. Addiction and cognition. Addict Sci Clin Pract. 2010;5(2):4–14.22002448
   PubMedGoogle Scholar
• Hulse GK, Lautenschlager NT, Tait RJAO. Dementia associated with alcohol and other drug use. Int Psychogeriatr. 2005;17(Suppl 1):109–127. doi:10.1017/S1041610205001985
   PubMed Web of Science ®Google Scholar
• Bezinović P, Malatestinić D. Perceived exposure to substance use and risk-taking behavior in early adolescence: cross-sectional study. Croat Med J. 2009;50(2):157–164. doi:10.3325/cmj.2009.50.15719399949
   PubMedGoogle Scholar
• Sklar AL, Gilbertson R, Boissoneault J, Prather R, Nixon SJ. Differential effects of moderate alcohol consumption on performance among older and younger adults. Alcohol Clin Exp Res. 2012;36(12):2150–2156. doi:10.1111/j.1530-0277.2012.01833.x22591190
   PubMedGoogle Scholar
• Gilbertson R, Ceballos NA, Prather R, Nixon SJ. Effects of acute alcohol consumption in older and younger adults: perceived impairment versus psychomotor performance. J Stud Alcohol Drugs. 2009;70(2):242–252. doi:10.15288/jsad.2009.70.24219261236
   PubMedGoogle Scholar
• Friedman TW, Robinson SR, Yelland GW. Impaired perceptual judgment at low blood alcohol concentrations. Alcohol. 2011;45(7):711–718doi:10.1016/j.alcohol.2010.10.00721145695
   PubMedGoogle Scholar
• Dry MJ, Burns NR, Nettelbeck T, Farquharson AL, White JM. Dose-related effects of alcohol on cognitive functioning. PLoS One. 2012;7(11):1–8. doi:10.1371/journal.pone.0050977
   Web of Science ®Google Scholar
• Berihu BA, Asfeha GG, Welderufael AL, Debeb YG, Zelelow YBBH. Toxic effect of khat (Catha edulis) on memory: systematic review and meta-analysis. J Neurosci Rural Pr. 2017;8(1):30–37. doi:10.4103/0976-3147.193524
   PubMedGoogle Scholar
• Colzato LS, Ruiz MJ, van den Wildenberg WPM, Hommel B. Khat use is associated with impaired working memory and cognitive flexibility. PLoS One. 2011;6(6):1–6. doi:10.1371/journal.pone.0020602
   Web of Science ®Google Scholar
• Hoffman R, Al’Absi M. Working memory and speed of information processing in chronic khat users: preliminary findings. Eur Addict Res. 2013;19(1):1–6. doi:10.1159/00033828522948202
   PubMedGoogle Scholar
• Yideg Yitbarek G, Mossie Ayana A, Bariso Gare M, Garedew Woldeamanuel G. Prevalence of cognitive impairment and its predictors among HIV/AIDS patients on antiretroviral therapy in Jimma University Medical Center, Southwest Ethiopia. Psychiatry J. 2018;2018:1–7.
   Google Scholar
• Wood S, Sage JR, Shuman T, Anagnostaras SG. Psychostimulants and cognition: A continuum of behavioral and cognitive activation. Pharmacol Rev. 2014;66(1):193–221. doi:10.1124/pr.112.00705424344115
   PubMed Web of Science ®Google Scholar
• Chiesi A, Vella S, Dally LG, et al. Epidemiology of AIDS dementia complex in Europe. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11(1):39–44.8528731
   PubMedGoogle Scholar
• Goodkin K, Shapshak P, Metsch LR, et al. Cocaine abuse and HIV-1 infection: epidemiology and neuropathogenesis. J Neuroimmunol. 1998;83(1–2):88–101. doi:10.1016/S0165-5728(97)00225-79610677
   PubMed Web of Science ®Google Scholar
• Tyor WR, Middaugh LD. Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex? J Leukoc Biol. 1999;65(4):475–481. doi:10.1002/jlb.65.4.47510204576
   PubMed Web of Science ®Google Scholar
• Nath A, Hauser KF, Wojna V, et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr. 2002;31(Suppl 2):S6269. doi:10.1097/00126334-200210012-00006
   Web of Science ®Google Scholar
• Soontornniyomkij V, Kesby JP, Morgan EE, et al. Effects of HIV and methamphetamine on brain and behavior: evidence from human studies and animal models. J Neuroimmune Pharmacol. 2016;11(3):495–510. doi:10.1007/s11481-016-9699-027484318
   PubMed Web of Science ®Google Scholar
• Attonito JM, Dévieux JG, Lerner BD, Hospital MM, Rosenberg R. Exploring substance use and HIV treatment factors associated with neurocognitive impairment among people living with HIV/AIDS. Front Public Health. 2014;2:105. doi:10.3389/fpubh.2014.0010525157345
   PubMedGoogle Scholar
• Koob GF, Schulkin J. Addiction and stress: an allostatic view. Neurosci Biobehav Rev. 2019;106(September2018):245–262. doi:10.1016/j.neubiorev.2018.09.00830227143
   PubMedGoogle Scholar
• Salahuddin MF, Qrareya AN, Mahdi F, et al. Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice. Horm Behav. 2020;119:104649. doi:10.1016/j.yhbeh.2019.10464931821792
   PubMedGoogle Scholar
• Clifford DB, Ances BM. HIV-Associated Neurocognitive Disorder (HAND). Lancet Infect Dis. 2013;13(11):976–986.24156898
   PubMed Web of Science ®Google Scholar
• Nightingale S, Winston A, Letendre S, et al. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13(11):1139–1151. doi:10.1016/S1474-4422(14)70137-125316020
   PubMed Web of Science ®Google Scholar
• Ettenhofer ML, Foley J, Castellon SA, Hinkin CH. Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology. 2010;74(15):1217–1222. doi:10.1212/WNL.0b013e3181d8c1ca20220123
   PubMed Web of Science ®Google Scholar
• Bloch M, Kamminga J, Jayewardene A, et al. A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review. Clin Infect Dis. 2016;63(5):687–693.27325690
   PubMed Web of Science ®Google Scholar
• Baron RM, Kenny D. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Personality Soc Psychol. 1986;51(6):1173–1182. doi:10.1037/0022-3514.51.6.1173
   PubMed Web of Science ®Google Scholar
• Milanini B, Paul R, Bahemana E, et al. AST. Limitations of the international HIV dementia scale in the current era. AIDS. 2018;32(17):2477–2483. doi:10.1097/QAD.000000000000196830134293
   PubMed Web of Science ®Google Scholar